Global CDMO PEGs Solutions

Polyethylene Glycol Manufacturers and Suppliers in India

PEGylated Drugs Manufacturers in India

Shilpa Pharma is a leading polyethylene glycol manufacturer in India, specializing in the development and supply of high-quality PEG formulations for various therapeutic applications. With advanced R&D capabilities and GMP-compliant manufacturing facilities, we provide innovative PEGylation solutions that enhance drug stability, solubility, and pharmacokinetic profiles.

Our expertise spans both oncology and non-oncology drugs, delivering reliable, tailor-made PEGylated drug solutions for global pharmaceutical companies. Backed by strong knowledge in PEGylation chemistry, drug conjugation, and scalable production, Shilpa Pharma ensures high-quality products that meet international regulatory standards.

Committed to innovation, quality, and compliance, we support our clients with comprehensive documentation, IPR assistance, and global submission-ready data. With a focus on enhancing drug efficacy and patient outcomes, Shilpa Pharma stands as a trusted name among polyethylene glycol drug manufacturers in India. For PEG drug enquiries, mail us at: info@maroon-shark-777574.hostingersite.com.

Offering Complete Range of Polyethylene Glycol Pharmaceuticals

Sr No. Category Name Molecular Weight (Mn) / PDI Compound Description Enquire
1 Various Molecular weights of Methoxy PEG Mn: 3kDa, 5kDa, 10kDa, 20kDa with low PDI Enquire Now
2 Poly(2-ethyloxazoline) Average Mn: 3500–6500 (PDI ≤1.3),
Average Mn: 8500–12500 (PDI ≤1.4),
Average Mn: 17500–22500 (PDI ≤1.5)
PEOz is amorphous, water-soluble, stable with temperature Enquire Now
3 Monodisperse PEG Diols (PEG6, PEG8, PEG9, PEG12) 6, 8, 9, 12 kDa with low PDI Enquire Now
4 Poly(ethylenimine hydrochloride) Average Mn: 4000–7000 (PDI ≤1.5),
Average Mn: 8000–12000 (PDI ≤1.6),
Average Mn: 17000–22000 (PDI ≤1.6)
High charge density, interacts with DNA; used in PEI & PEI-β-mPEG delivery vectors Enquire Now
5 Various Molecular weights of Methoxy PEG-block-Poly(ethyleneimine) Mn: 12, 25 kDa with low PDI Enquire Now
6 Linear Poly(ethyleneimine) Average Mn: 2000–3000 (PDI ≤1.5),
Average Mn: 4000–6000 (PDI ≤1.6),
Average Mn: 7000–9000 (PDI ≤1.6)
Enquire Now
7 Various Molecular weights of Methoxy PEG-block-Poly(2-ethyloxazoline) Mn: 8, 20, 40 kDa with low PDI Enquire Now
8 Poly[2-(dialkylamino)ethyl methacrylate] derivatives Different derivatives shown (dimethylamino, diethylamino, diisopropylamino) Enquire Now
9 Various Molecular weights of Methoxy PEG-block-PLGA Various MW with low PDI Enquire Now

Disclaimer

The content on this website is for general informational purposes only. While we strive for accuracy, Shilpa Pharma makes no warranties regarding the completeness, reliability, or suitability of the information. For detailed product specifications, regulatory documentation, or inquiries, please contact us directly.

GLOBAL LEADERS IN PEGs MANUFACTURING FOR PHARMA & BIOMEDICAL APPLICATIONS

At Shilpa Pharma, we specialize in the manufacturing of high-purity Polyethylene Glycols (PEGs) engineered for advanced pharmaceutical and biomedical applications. Here’s why leading global pharma companies partner with us:

GMP-Certified Manufacturing Excellence

State-of-the-art GMP facilities ensuring consistent quality, scalability, and batch-to-batch reliability.

Specialized PEGs Expertise for Pharma & Biomedicine

Deep expertise in PEG synthesis and functionalization designed specifically for drug delivery, biologics, and biomedical use.

Custom PEG Development & R&D Capabilities

Tailored PEG molecular weights, end-group modifications, and functional PEGs developed to meet complex formulation and conjugation needs.

Trusted Global PEGs Partner

Decades of experience, strong international presence, and long-term partnerships with leading pharmaceutical innovators worldwide.

End-to-End CDMO Support

Comprehensive support from PEG development and scale-up to analytical validation, documentation, and commercialization.

Shilpa Pharma’s Portfolio of Pharmaceutical Polyethylene Glycol Manufacturing

Polyethylene Glycol

Shilpa Pharma offers a comprehensive portfolio of pharmaceutical-grade Polyethylene Glycols (PEGs) engineered to support advanced drug delivery, biologics, and biomedical applications. With strong scientific expertise and robust manufacturing capabilities, we deliver high-purity PEG solutions designed to meet the evolving needs of global pharmaceutical innovators.

Our portfolio includes a wide range of Methoxy PEGs (mPEGs) across multiple molecular weights, PEG diols, and functionalized PEG derivatives developed for precision conjugation and formulation flexibility. We also manufacture PEGylated linkers and activated PEGs that enable effective PEGylation of peptides, proteins, and small molecules, improving solubility, stability, and therapeutic performance.

In addition to standard PEG grades, Shilpa Pharma provides custom PEG synthesis and functionalization, including block copolymers and specialized linker chemistries, supporting research, clinical development, and commercial manufacturing.

All PEG products are manufactured in GMP-compliant facilities and adhere to stringent quality standards. Our operations are accredited by major international regulatory authorities, including USFDA, EU GMP, ANVISA, COFEPRIS, TGA, PMDA, and KFDA, ensuring global acceptance and regulatory confidence.

Driven by innovation, quality, and reliability, Shilpa Pharma remains a trusted global partner for pharmaceutical PEG manufacturing.

Didn’t find the pharma PEGs you’re looking for?

No worries! We love challenges—contact us to discuss custom CDMO PEGs solutions tailored to your needs.

Shilpa Pharma: Leading Polyethylene Glycol Manufacturing Company in India

Shilpa Pharma is recognized as a leading Polyethylene Glycol (PEG) manufacturing company in India, trusted by global pharmaceutical and biomedical innovators for quality, consistency, and scientific excellence. With world-class cGMP-compliant manufacturing facilities and multiple international regulatory approvals, we deliver pharmaceutical-grade PEGs that meet the highest global standards.

Our expertise covers a wide spectrum of PEGs and PEG derivatives, ranging from standard grades to highly specialized, difficult-to-manufacture polymer APIs used in advanced drug delivery systems and biomedical applications. Backed by strong process chemistry capabilities and advanced analytical infrastructure, we ensure precise control over molecular weight, purity, and performance.

Shilpa Pharma is also a reliable CDMO partner, supporting clients from development and scale-up to commercial manufacturing. Our proven track record of successful global collaborations reflects our commitment to innovation, regulatory compliance, and supply reliability.

Driven by science and quality, Shilpa Pharma continues to strengthen its position as a preferred Indian manufacturer of high-performance PEG solutions for regulated global markets.

Explore Our Other Product Range

Get in Touch: Your Trusted Partner in PEGs Manufacturing

Get a Quote

0+

Happy Customers

0+

Projects Successfully Completed

0

Established

0+

PhD Experts Driving R&D Excellence

0+

Team Size

0+

World-Class API Manufacturing Sites

0+

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Questions & Answers

Our FAQ's

Everything You Need to Know About PEGs development  in India at Shilpa Pharma

Polyethylene Glycols (PEGs) are widely used in pharmaceuticals to improve solubility, stability, bioavailability, and half-life of drugs, especially in biologics and advanced drug delivery systems.

Shilpa Pharma combines deep polymer science expertise, cGMP-compliant manufacturing, advanced analytics, and global regulatory approvals, making it a trusted partner for pharmaceutical-grade PEG development.

Yes, we provide customized PEG synthesis, molecular weight control, functionalization, and PEGylation-ready derivatives to meet specific formulation and conjugation requirements.

Our portfolio includes mPEGs, PEG diols, functionalized PEGs, PEG linkers, activated PEGs, and specialized PEG derivatives for drug delivery and biomedical applications.

All PEGs are produced in cGMP facilities accredited by major global authorities, ensuring suitability for regulated markets and commercial pharmaceutical use.

Yes, we support the complete lifecycle—from lab-scale development and process optimization to large-scale manufacturing and commercial supply.

Absolutely. We offer PEGs designed for PEGylation and conjugation, helping enhance drug performance, stability, and therapeutic efficacy.

Our PEG solutions support pharmaceutical, biotech, biomedical, and advanced drug delivery industries across global markets.

Shilpa Pharma provides end-to-end CDMO services, including PEG design, process development, scale-up, GMP manufacturing, analytical testing, and regulatory documentation support.

Yes, we support PEGs projects across all stages—from early research and preclinical development to clinical supply and commercial-scale manufacturing.

We follow robust quality systems, validated processes, advanced analytical controls, and strict GMP compliance to ensure batch-to-batch consistency.

Absolutely. All CDMO engagements follow strict confidentiality agreements and IP protection frameworks to safeguard client innovations.

Yes, our strong process chemistry expertise and scalable manufacturing infrastructure enable reliable production of complex and highly specialized PEGs for global markets.

Countries We Serve in

Polyethylene Glycol Manufacturers in India | Shilpa Pharma

In the growing chemical and pharmaceutical sectors, polyethylene glycol (PEG) plays a critical role in applications ranging from drug formulation to cosmetics and industrial processes. As demand for high-quality PEG increases, businesses are actively seeking reliable polyethylene glycol manufacturers in India who can meet global quality standards, ensure supply consistency, and offer competitive pricing. Shilpa Pharma is among the leading PEG manufacturers in India, known for its strong manufacturing capabilities, stringent quality control, and customer-centric approach. We produce a wide range of polyethylene glycol grades that comply with pharmacopoeial standards (IP, BP, USP), making them suitable for both pharmaceutical and industrial use. As experienced polyethylene glycol suppliers, we understand the critical needs of B2B clients—timely deliveries, consistent batch quality, regulatory documentation, and technical support. Our modern manufacturing facilities and commitment to innovation make Shilpa Pharma a preferred partner for businesses across sectors. If you’re sourcing from polyethylene glycol manufacturers for bulk or contract supply, Shilpa Pharma offers a reliable, scalable, and quality-assured solution.

What is Polyethylene Glycol?

Polyethylene Glycol (PEG) is a polyether compound widely used across various industries for its versatility, solubility, and low toxicity. It is produced through the polymerization of ethylene oxide and is available in a range of molecular weights, which determines its physical form (liquid, semi-solid, or solid) and application. In the pharmaceutical and healthcare industries, PEG is commonly used as a solvent, binder, and drug delivery agent. It enhances the solubility and bioavailability of active pharmaceutical ingredients (APIs), making it a key excipient in tablets, ointments, and injectable formulations.

Common Applications of PEG:

  1. Pharmaceutical formulations (laxatives, ointments, tablets)
  2. Personal care products (moisturizers, shampoos)
  3. Industrial uses (lubricants, coatings, surfactants)
  4. Food processing (as anti-foaming or coating agents)

Global Regulatory Approvals and Compliance

As a globally recognized Polyethylene Glycol supplier in India, Shilpa’s manufacturing facilities meet the highest international quality standards. The company holds approvals and certifications from several major regulatory bodies, ensuring consistent product quality and regulatory compliance. Our facilities are:
  • USFDA Approved (United States Food & Drug Administration)
  • EU GMP Certified (European Union Good Manufacturing Practice)
  • ANVISA Approved (Brazilian Health Regulatory Agency)
  • COFEPRIS Approved (Mexico)
  • TGA Certified (Australia)
  • PMDA Approved (Japan)
  • KFDA Certified (South Korea)
These certifications position Shilpa Pharma as a trusted partner for both regulated and semi-regulated markets.

Why Choose Shilpa PEGs Manufacturing in India?

When sourcing high-quality polyethylene glycols (PEGs), global businesses prioritize reliability, compliance, and consistency. Shilpa Pharma has established itself as a leading name in PEG manufacturing in India, combining technical expertise with strong manufacturing capabilities as a trusted Contract Development and Manufacturing Organization (CDMO).

Proven CDMO Capabilities

As an experienced CDMO, Shilpa Pharma partners with pharmaceutical, cosmetic, and industrial clients to deliver customized PEG solutions. From development to commercial production, our team supports clients through every stage, ensuring that formulations meet both functional needs and regulatory standards.

Our CDMO services include:

  • Custom PEG formulation and grade development

  • Scale-up from pilot to commercial batches

  • Regulatory support and documentation

  • Quality control aligned with USP, BP, IP standards

We go beyond manufacturing — we act as a strategic partner invested in your product’s success.

Trusted by Global Markets

Shilpa Pharma is the preferred PEG supplier for companies across China, Japan, Europe, and other international markets. This global trust is built on our consistent product quality, robust compliance framework, and responsive customer service.

Why international clients choose Shilpa Pharma:

  • High-purity PEGs for pharmaceutical and industrial use

  • Consistent quality and documentation

  • Scalable production capacity

  • On-time delivery and global logistics support

Our track record of international partnerships reflects our commitment to excellence and reliability.

Manufacturing Strength in India

Operating from India, Shilpa Pharma combines cost-effective manufacturing with state-of-the-art infrastructure. Our facilities are GMP-compliant and equipped to handle diverse molecular weights and specifications of polyethylene glycol, offering flexibility for both small and large-scale orders.

Fill the Form